Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Lennox–Gastaut syndrome (LGS) is a complex, rare, and severe childhood-onset epilepsy. It is characterized by multiple and concurrent seizure types, cognitive dysfunction, and slow spike waves on electroencephalogram (EEG). Typically, it presents in children aged 3–5 years and can persist into adulthood.
Corpus callosotomy is a surgical procedure used for treating refractory generalized seizures caused due to Lennox-Gastaut syndrome (LGS). However, this surgical procedure involves craniotomy with microdissection. Therefore, companies are focusing on the development of minimally invasive procedures such as MR-guided laser interstitial thermal therapy (MRg-LITT). MRg-LITT has emerged as a safe, effective, and durable alternative of traditional open corpus callosotomy. The efficacy of MRg-LITT is also being tested in advanced surgical ablation of epileptogenic foci and corpus callosotomy. This will further boost its adoption in LGS treatment. Such advancements in surgical treatments will be one of the key trends that will impact LGS market growth in the coming years.
The report details the trend, potential and market size of Lennox-Gastaut Syndrome Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Lennox-Gastaut Syndrome Treatmentmarket, defines the market attractiveness level of Lennox-Gastaut Syndrome Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Lennox-Gastaut Syndrome Treatment industry, describes the types of Lennox-Gastaut Syndrome Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Lennox-Gastaut Syndrome Treatment market and the development prospects and opportunities of Lennox-Gastaut Syndrome Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Lennox-Gastaut Syndrome Treatment market in Chapter 13.
By Player:
Johnson & Johnson Services, Inc
Supernus Pharmaceuticals, Inc
GlaxoSmithKline plc
Eisai Co, Ltd
H Lundbeck A/S
By Type:
Non-surgical Treatment
Surgical Treatment
By End-User:
Hospital
Clinic
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Lennox-Gastaut Syndrome Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Lennox-Gastaut Syndrome Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Lennox-Gastaut Syndrome Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Lennox-Gastaut Syndrome Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Lennox-Gastaut Syndrome Treatment Market Analysis and Outlook to 2022
-
7.1 Global Lennox-Gastaut Syndrome Treatment Consumption (2017-2022)
-
7.2 United States Lennox-Gastaut Syndrome Treatment Consumption (2017-2022)
-
7.3 Europe Lennox-Gastaut Syndrome Treatment Consumption (2017-2022)
-
7.4 China Lennox-Gastaut Syndrome Treatment Consumption (2017-2022)
-
7.5 Japan Lennox-Gastaut Syndrome Treatment Consumption (2017-2022)
-
7.6 India Lennox-Gastaut Syndrome Treatment Consumption (2017-2022)
-
7.7 South Korea Lennox-Gastaut Syndrome Treatment Consumption (2017-2022)
8 Region and Country-wise Lennox-Gastaut Syndrome Treatment Market Analysis and Outlook to 2028
-
8.1 Global Lennox-Gastaut Syndrome Treatment Consumption Forecast (2022-2028)
-
8.2 United States Lennox-Gastaut Syndrome Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Lennox-Gastaut Syndrome Treatment Consumption Forecast (2022-2028)
-
8.4 China Lennox-Gastaut Syndrome Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Lennox-Gastaut Syndrome Treatment Consumption Forecast (2022-2028)
-
8.6 India Lennox-Gastaut Syndrome Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Lennox-Gastaut Syndrome Treatment Consumption Forecast (2022-2028)
9 Global Lennox-Gastaut Syndrome Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Lennox-Gastaut Syndrome Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Non-surgical Treatment Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Surgical Treatment Consumption and Growth Rate (2017-2022)
-
9.2 Global Lennox-Gastaut Syndrome Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Lennox-Gastaut Syndrome Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Lennox-Gastaut Syndrome Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Non-surgical Treatment Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Surgical Treatment Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Lennox-Gastaut Syndrome Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Lennox-Gastaut Syndrome Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Lennox-Gastaut Syndrome Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Lennox-Gastaut Syndrome Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Lennox-Gastaut Syndrome Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Lennox-Gastaut Syndrome Treatment Market Competitive Analysis
-
14.1 Johnson & Johnson Services, Inc
-
14.1.1 Johnson & Johnson Services, Inc Company Details
-
14.1.2 Johnson & Johnson Services, Inc Lennox-Gastaut Syndrome Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Johnson & Johnson Services, Inc Lennox-Gastaut Syndrome Treatment Product and Service
-
14.2 Supernus Pharmaceuticals, Inc
-
14.2.1 Supernus Pharmaceuticals, Inc Company Details
-
14.2.2 Supernus Pharmaceuticals, Inc Lennox-Gastaut Syndrome Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Supernus Pharmaceuticals, Inc Lennox-Gastaut Syndrome Treatment Product and Service
-
14.3 GlaxoSmithKline plc
-
14.3.1 GlaxoSmithKline plc Company Details
-
14.3.2 GlaxoSmithKline plc Lennox-Gastaut Syndrome Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 GlaxoSmithKline plc Lennox-Gastaut Syndrome Treatment Product and Service
-
14.4 Eisai Co, Ltd
-
14.4.1 Eisai Co, Ltd Company Details
-
14.4.2 Eisai Co, Ltd Lennox-Gastaut Syndrome Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Eisai Co, Ltd Lennox-Gastaut Syndrome Treatment Product and Service
-
14.5 H Lundbeck A/S
-
14.5.1 H Lundbeck A/S Company Details
-
14.5.2 H Lundbeck A/S Lennox-Gastaut Syndrome Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 H Lundbeck A/S Lennox-Gastaut Syndrome Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Lennox-Gastaut Syndrome Treatment
-
Figure Lennox-Gastaut Syndrome Treatment Picture
-
Table Global Lennox-Gastaut Syndrome Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Lennox-Gastaut Syndrome Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Lennox-Gastaut Syndrome Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Lennox-Gastaut Syndrome Treatment Consumption by Country (2017-2022)
-
Figure United States Lennox-Gastaut Syndrome Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Lennox-Gastaut Syndrome Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Lennox-Gastaut Syndrome Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Lennox-Gastaut Syndrome Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Lennox-Gastaut Syndrome Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Lennox-Gastaut Syndrome Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Lennox-Gastaut Syndrome Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Lennox-Gastaut Syndrome Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Lennox-Gastaut Syndrome Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Lennox-Gastaut Syndrome Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Lennox-Gastaut Syndrome Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Lennox-Gastaut Syndrome Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Lennox-Gastaut Syndrome Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-surgical Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Surgical Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Non-surgical Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Surgical Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Lennox-Gastaut Syndrome Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Lennox-Gastaut Syndrome Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Johnson & Johnson Services, Inc (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Services, Inc Lennox-Gastaut Syndrome Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Services, Inc Lennox-Gastaut Syndrome Treatment Product and Service
-
Table Supernus Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table Supernus Pharmaceuticals, Inc Lennox-Gastaut Syndrome Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Supernus Pharmaceuticals, Inc Lennox-Gastaut Syndrome Treatment Product and Service
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Lennox-Gastaut Syndrome Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Lennox-Gastaut Syndrome Treatment Product and Service
-
Table Eisai Co, Ltd (Foundation Year, Company Profile and etc.)
-
Table Eisai Co, Ltd Lennox-Gastaut Syndrome Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Co, Ltd Lennox-Gastaut Syndrome Treatment Product and Service
-
Table H Lundbeck A/S (Foundation Year, Company Profile and etc.)
-
Table H Lundbeck A/S Lennox-Gastaut Syndrome Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table H Lundbeck A/S Lennox-Gastaut Syndrome Treatment Product and Service
-
